Intelligence · Clinical Pipeline
Tonix Pharmaceuticals Holding Pipeline
All ClinicalTrials.gov programs at Tonix Pharmaceuticals Holding — phase, modality, and trial IDs.
- Programs
- 14
Quick answer
Tonix Pharmaceuticals Holding has 14 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Imaging procedure to measure the distribution of a newly developed radiolabeled ligand for the oxytocin receptor
Tonix Pharmaceuticals Holding
Pain, Face
1 trial -
Intranasal Oxytocin (IN-OXT)
Tonix Pharmaceuticals Holding
Vasopressin Deficiency
1 trial -
SL TNX-102 2.4 mg at pH 3.5
Tonix Pharmaceuticals Holding
Healthy Adults
1 trial -
SL TNX-102 at 2.4 mg
Tonix Pharmaceuticals Holding
Healthy Adults
1 trial -
TNX-102 SL
Tonix Pharmaceuticals Holding
Healthy Subjects
1 trial -
TNX-102 SL
Tonix Pharmaceuticals Holding
Healthy Subjects (HS)
1 trial -
TNX-102 SL 5.6 mg
Tonix Pharmaceuticals Holding
Healthy Subjects
1 trial -
TNX-102 SL Tablet
Tonix Pharmaceuticals Holding
Pharmakokinetic
1 trial -
TNX-102 SL Tablets at 2.8 mg
Tonix Pharmaceuticals Holding
Healthy Adults
1 trial -
TNX-1500
Tonix Pharmaceuticals Holding
Phase 1 First-in-human Study Involving Healthy Subjects
1 trial -
TNX-201 35 mg
Tonix Pharmaceuticals Holding
Healthy
1 trial -
TNX-2110
Tonix Pharmaceuticals Holding
Detection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2
1 trial -
Treatment A
Tonix Pharmaceuticals Holding
Healthy
1 trial -
Treatment A
Tonix Pharmaceuticals Holding
Healthy Adults
1 trial
Frequently asked questions
How many pipeline programs does Tonix Pharmaceuticals Holding have?
14 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs